Showing results (11-20 of 250) with videos related to
Sort By:
Pageof 25
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 15, 2017
Serum S100B levels correlate with stage, N status, mitotic rate and disease outcome in melanoma patients independent to LDHAthanasios Karonidis, Marina Mantzourani, Helen Gogas, et al.Expert Review of Anticancer Therapy|January 7, 2020
Identifying the optimum first-line therapy in BRAF-mutant metastatic melanomaDimitrios C Ziogas, Frosso Konstantinou, Spyros Bouros, et al.Melanoma Research|June 4, 2019
New primary melanoma in a patient under triple therapy with vemurafenib, cobimetinib, and atezolizumab for metastatic melanomaPanagiotis T Diamantopoulos, Eleftheria Lakiotaki, Georgios Kyriakakis, et al.JCEM Case Reports|May 13, 2025
An Extremely Rare Case of Immune Checkpoint Inhibitors-Related Hypoparathyroidism and a Critical Literature ReviewSpyridon Kazanas, Amalia Anastasopoulou, Dimitrios Ziogas, et al.Seminars in Immunopathology|February 1, 2011
Prognostic significance of autoimmunity during treatment of melanoma with interferonMichal T Krauze, Ahmad Tarhini, Helen Gogas, et al.Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Advances in adjuvant therapy: potential for prognostic and predictive biomarkersDiwakar Davar, Ahmad A Tarhini, Helen Gogas, et al.International Journal of Surgical Oncology|December 23, 2014
Emergency surgery for metastatic melanomaDimitrios Mantas, Petros Tsaparas, Petros Charalampoudis, et al.Therapeutic Advances in Medical Oncology|October 22, 2020
An overview of antibody-drug conjugates in oncological practiceCharalampos Theocharopoulos, Panagiotis-Petros Lialios, Helen Gogas, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 13, 2017
Inflammatory Myopathy and Axonal Neuropathy in a Patient With Melanoma Following Pembrolizumab TreatmentPanagiotis T Diamantopoulos, Katerina Tsatsou, Olga Benopoulou, et al.Therapeutic Advances in Hematology|March 20, 2023
Challenges in the treatment of melanoma with BRAF and MEK inhibitors in patients with sickle cell disease: case report and review of the literaturePanagiotis T Diamantopoulos, Amalia Anastasopoulou, Maria Dimopoulou, et al.Pageof 25